Galván, Sandra TorresFlores-López, MaríaRomero-Sanchiz, PabloRequena-Ocaña, NereaPorras-Perales, OscarNogueira-Arjona, RaquelMayoral, FermínAraos, PedroSerrano, AntoniaMuga, RobertoPavón, Francisco JavierGarcía-Marchena, Nuriade Fonseca, Fernando Rodríguez2023-02-092023-02-092021-07-01http://hdl.handle.net/10668/18139Granulocyte colony-stimulating factor (G-CSF) has raised much interest because of its role in cocaine addiction in preclinical models. We explored the plasma concentrations of G-CSF in patients diagnosed with substance use disorder (SUD) and highly comorbid psychiatric disorders. In particular, we investigated the association between G-CSF concentrations and comorbid major depressive disorder (MDD) in patients with cocaine and alcohol use disorders (CUD and AUD, respectively). Additionally, patients with MDD but not SUD were included in the study. Three hundred and eleven participants were enrolled in this exploratory study: 136 control subjects, 125 patients with SUD (SUD group) from outpatient treatment programs for cocaine (N = 60, cocaine subgroup) and alcohol (N = 65, alcohol subgroup), and 50 patients with MDD but not SUD (MDD group) from primary-care settings. Participants were assessed based on DSM-IV-TR criteria, and a blood sample was collected to examine the plasma concentrations of G-CSF. G-CSF concentrations were negatively correlated with age in the entire sample (r = - 0.233, p enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/AdultAlcoholismCocaine-Related DisordersComorbidityDepressive Disorder, MajorDiagnosis, Dual (Psychiatry)FemaleGranulocyte Colony-Stimulating FactorHumansMaleMiddle AgedSubstance-Related Disordersresearch article34211033open access10.1038/s41598-021-93075-12045-2322PMC8249412https://www.nature.com/articles/s41598-021-93075-1.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249412/pdf